HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevention of clinical and histological signs of MOG-induced experimental allergic encephalomyelitis by prolonged treatment with recombinant human EGF.

Abstract
Epidermal growth factor (EGF) represents the prototype of the group I EGF family. The pleiotropic effects of the EGF have attracted attention to the possibility that it could be implicated in autoimmune diseases, such as Multiple Sclerosis (MS). We show here that treatment with EGF, as a late prophylactic regime, improved the clinical and histological features of EAE, a preclinical model of MS. In silico analysis further corroborated these findings by demonstrating that EGF receptors are less expressed in CNS from patients with MS as compared to controls. Taken together these data provide clear-cut in vivo proof of concept for a beneficial role of exogenously administered EGF in MS, that may, therefore, represent a novel therapeutic approach.
AuthorsFerdinando Nicoletti, Emanuela Mazzon, Paolo Fagone, Katia Mangano, Santa Mammana, Eugenio Cavalli, Maria Sofia Basile, Placido Bramanti, Giuseppe Scalabrino, Alois Lange, Francois Curtin
JournalJournal of neuroimmunology (J Neuroimmunol) Vol. 332 Pg. 224-232 (07 15 2019) ISSN: 1872-8421 [Electronic] Netherlands
PMID31100693 (Publication Type: Journal Article)
CopyrightCopyright © 2019 Elsevier B.V. All rights reserved.
Chemical References
  • Myelin-Oligodendrocyte Glycoprotein
  • Peptide Fragments
  • Recombinant Proteins
  • myelin oligodendrocyte glycoprotein (35-55)
  • Epidermal Growth Factor
  • Dexamethasone
  • ErbB Receptors
Topics
  • Animals
  • Brain (pathology)
  • CD4-Positive T-Lymphocytes (immunology, metabolism)
  • Dexamethasone (therapeutic use)
  • Encephalomyelitis, Autoimmune, Experimental (chemically induced, drug therapy, pathology, prevention & control)
  • Epidermal Growth Factor (administration & dosage, biosynthesis, genetics, therapeutic use)
  • ErbB Receptors (analysis, biosynthesis, genetics)
  • Female
  • Humans
  • Mice, Inbred C57BL
  • Myelin-Oligodendrocyte Glycoprotein (toxicity)
  • Peptide Fragments (toxicity)
  • Recombinant Proteins (administration & dosage, therapeutic use)
  • Spinal Cord (chemistry, pathology)
  • Transcriptome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: